DIGITAL SURGERY LIMITED
Get an alert when DIGITAL SURGERY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-01-31 (in 8mo)
Last filed for 2025-04-25
Confirmation statement due
2027-03-15 (in 10mo)
Last made up 2026-03-01
Watchouts
None on the register
Cash
£929K
-50.2% vs 2024
Net assets
-£32M
-1,551.8% vs 2024
Employees
238
+12.8% vs 2024
Profit before tax
-£29M
+4% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2025-04-25
| Metric | Trend | 2024-04-26 | 2025-04-25 |
|---|---|---|---|
| Turnover | £1,573,000 | £3,199,000 | |
| Operating profit | -£30,515,000 | -£27,342,000 | |
| Profit before tax | -£29,763,000 | -£28,571,000 | |
| Net profit | -£30,602,000 | -£29,873,000 | |
| Cash | £1,864,000 | £929,000 | |
| Total assets less current liabilities | -£1,925,000 | -£31,798,000 | |
| Net assets | -£1,925,000 | -£31,798,000 | |
| Equity | -£1,925,000 | -£31,798,000 | |
| Average employees | 211 | 238 | |
| Wages | £16,247,000 | £14,406,000 | |
| Directors' remuneration | £823,000 | £426,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-04-25 vs 2024-04-26
-
Turnover
+103.4%
£1,573,000 £3,199,000
-
Cash
-50.2%
£1,864,000 £929,000
-
Net assets
-1,551.8%
-£1,925,000 -£31,798,000
-
Employees
+12.8%
211 238
-
Operating profit
+10.4%
-£30,515,000 -£27,342,000
-
Profit before tax
+4%
-£29,763,000 -£28,571,000
-
Wages
-11.3%
£16,247,000 £14,406,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-04-26 | 2025-04-25 |
|---|---|---|---|
| Operating margin | -1939.9% | -854.7% | |
| Net margin | -1945.5% | -933.8% | |
| Return on capital employed | 1585.2% | 86.0% | |
| Current ratio | 0.70x | 0.29x | |
| Interest cover | -7628.75x | -22.21x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- DIGITAL SURGERY LIMITED 2017-11-29 → present
- KINOSIS LTD 2011-03-01 → 2017-11-29
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Medtronic plc has provided a letter of support to provide funding for company expenditure and to enable it to meet its liabilities for the foreseeable future.”
Significant events
- “On 14 July 2025, Covidien Group S.a.r.l. made a capital contribution of USD 62,500,000 to Digital Surgery Limited in exchange for shares and share premium. This transaction occurred after the reporting period and does not affect the amounts recognised in the financial statements for the period ended 25th of April 2025.”
- “On 19 November 2025, Covidien Group S.a.r.l. made a capital contribution of USD 40,000,000 to Digital Surgery Limited in exchange for shares and share premium. This transaction occurred after the reporting period and does not affect the amounts recognised in the financial statements for the period ended 25th ofApril 2025.”
- “After the financial period ended 25 April 2025, it has been brought to the attention of the directors that the Company had transferred the benefit of net operating losses ("NOLs") to four Group entities without receiving any monetary consideration (...). To address this issue, the directors have developed a remediation plan to be implemented during the financial period ending on 24 April 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ANDERSON, Matthew John | Director | 2025-07-18 | Aug 1974 | American |
| MURGATROYD, George Bruce | Director | 2023-01-20 | Jan 1984 | British |
| TEMPLE, Lauren Yves | Director | 2025-11-03 | Mar 1990 | New Zealander |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BUCKLEY, Russell Christopher Franklin | Director | 2013-12-12 | 2017-08-29 |
| CHOW, Andre | Director | 2012-12-07 | 2022-12-20 |
| COOKSON, Alastair John Ivor | Director | 2018-09-18 | 2020-02-12 |
| DELHAYE, Arnaud | Director | 2024-11-01 | 2024-12-01 |
| DELHAYE, Arnaud | Director | 2020-02-12 | 2024-11-01 |
| EVANS, William Mark | Director | 2013-05-20 | 2020-02-12 |
| GANDHE, Advait Jayant | Director | 2011-03-01 | 2014-05-19 |
| MARINARO, Michael | Director | 2022-04-07 | 2025-07-18 |
| NEHME, Jean, Dr | Director | 2011-03-01 | 2023-12-29 |
| OETTING, Andrew | Director | 2017-08-29 | 2020-02-12 |
| OLDAKER, Julian Charles | Director | 2021-03-01 | 2026-01-13 |
| PURKAYASTHA, Sanjay, Dr | Director | 2012-12-07 | 2014-05-19 |
| ROSENGARTEN, Megan Rhiannon | Director | 2020-02-12 | 2022-04-07 |
| SPECTOR, David Alexander | Director | 2014-11-24 | 2018-09-18 |
| WADADLI, Aryn | Director | 2020-02-12 | 2021-03-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Medtronic Public Limited Company | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-02-12 | Active |
| Balderton Capital | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2017-08-29 |
Filing timeline
Last 20 of 162 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-02-02 | AA | accounts | Accounts with accounts type full | |
| 2026-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-25 | SH01 | capital | Capital allotment shares | |
| 2025-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-07-21 | SH01 | capital | Capital allotment shares | |
| 2025-07-18 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-18 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-30 | AA | accounts | Accounts with accounts type full | |
| 2025-03-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-22 | AA | accounts | Accounts with accounts type full | |
| 2024-01-29 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-03 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-03 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 2
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.